
GENDER FEATURES OF THE ANTIOXIDANT SYSTEM IN ISCHEMIC HEART DISEASE
Latipova K.Yu. , Andijan State Medical Institute, UzbekistanAbstract
The problem of coronary heart disease has acquired in recent years not only an important medicalcial, but also social significance due to the increase in morbidity, high mortality, and loss of working capacity at different ages [1].Currently, the issue of gender characteristics of the course of cardiovascular diseases (CVD) is being actively discussed in the world, which is relevant for the development of a differentiated approach to the treatment of cardiac pathology in men and women.Research in recent years indicates that further study of the circulatory regulatory systems is necessary to understand the pathogenesis of coronary heart disease.Expert recommendations to date do not contain any differences in approaches to the treatment of CVD in men and women.
Keywords
References
Abdurakhimov A.A., Mamutov R.Sh. Study of the prevalence of coronary heart disease and the possibility of preventive interventions in industrial teams. // Bulletin of the Association of Doctors of Uzbekistan. 2018. No. 4. P. 33-35.
Kotovskaya M.A., Solovyov S.K., Nikishina N.Yu. Risk factors for the development of atherosclerosis and clinical signs of cardiovascular disorders in patients at an early stage. // Rheumatology. 2015, No. 3, pp. 67-70.
Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. // Circulation. – 2001. -No. 104. – R. 365–372.
Bondar K. Yu. Antioxidant properties of simvastatin in patients with coronary heart disease with dyslipidemia / Artamoshina N. E., Bondar K. Yu., Belaya O. L., Baider L. M., Kuropteva Z. V. // Cardiovascular therapy and prevention. - 2012. - No. 6. - P. 16-22.
Bondar K.Yu. Atorvastatin and oxidative stress in ischemic heart disease with dyslipidemia / Bondar K.Yu., Belaya O.L., Lazutina O.M., Kuropteva Z.V., Baider L.M., Artamoshina N.E. Yakovleva T.V. // Clinical medicine.- 2012.-JV® 10.- P.34-38.
Kosnikova I.V., Ishankulova G.F., Belova O.A. Features of carbohydrate and protein-nitrogen metabolism in patients with atherosclerosis and ischemic heart disease. // Medical journal of Uzbekistan. 2005. No. 3. P. 52-55.
Kotovskaya M.A., Solovyov S.K., Nikishina N.Yu. Risk factors for the development of atherosclerosis and clinical signs of cardiovascular disorders in patients at an early stage. // Rheumatology. 2005, No. 3, P. 67-70.
Nasonov E.L. Immunological markers of atherosclerosis // Ter. archive, 2002; No. 5, pp. 80-85.
Paleev N.R., Paleev F.N. Cytokines and their role in the pathogenesis of heart diseases. Clinical medicine. 2004, No. 5, pp. 4-7.
Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. // Circulation. – 2001. -No. 104. – R. 365–372.
Uzui H., Harpf A., Liu M. et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines //Circulation. – 2002. - No. 106. – R.3024–3030.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.